Form 4: BIO-TECHNE Director Amy Herr Exercises Stock Options and Sells Shares
Insider Transaction Report
Amy E. Herr, a Director at BIO-TECHNE Corp, reported exercising stock options and subsequently selling a portion of the acquired shares on June 9, 2025.
Summary
- On June 9, 2025, Amy E. Herr, a Director of BIO-TECHNE Corp (TECH), exercised stock options to acquire 1,280 shares of common stock at an exercise price of $44.33 per share.
- Concurrently, Ms. Herr sold 1,280 shares of common stock at a weighted average price of $49.7694 per share, with prices ranging from $49.7471 to $49.8100.
- Following these transactions, Ms. Herr directly beneficially owns 1,040 shares of BIO-TECHNE Common Stock.
- Additionally, Ms. Herr's significant other indirectly beneficially owns 1,976 shares of Common Stock after the reported transactions.
- The filing also details various outstanding stock options and restricted stock units (RSUs) held directly and indirectly, with different exercise prices and vesting schedules extending through 2035.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving the exercise of stock options and a subsequent sale of shares, which is a common practice for liquidity or tax purposes. The volume of shares sold is not significant enough to indicate a strong positive or negative sentiment regarding the company's future prospects.
Positives
- The exercise of stock options indicates that the director saw value in acquiring shares at the exercise price.
- The director maintains significant direct and indirect beneficial ownership in the company following the transactions.
Negatives
- The sale of 1,280 shares by a director, even if for liquidity or tax purposes, can sometimes be perceived negatively by the market.
Future Outlook
The document outlines future vesting schedules for various stock options and restricted stock units held by the director and her significant other, with vesting dates extending through August 2028 and option expiration dates through February 2035, indicating future potential share acquisitions and liquidity events.
Industry Context
NA
Stakeholder Impact
- Shareholders: The sale of shares by a director could be perceived as a minor negative signal, but the small volume suggests minimal impact on overall market sentiment or share price.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- Continued vesting of various stock options and restricted stock units held by the reporting person and her significant other on scheduled dates.
- Potential future exercises of stock options and conversion of restricted stock units into common stock as they vest.
Key Dates
| Date | Description |
|---|---|
| 06/09/2025 | Date of stock option exercise and subsequent sale of common stock by Amy E. Herr. |
| 08/08/2025 | Expiration date for a stock option with an exercise price of $44.33, held indirectly by significant other. |
| 08/15/2025 | Vesting date for 520 shares of stock option with exercise price $120.46, 528 shares of stock option with exercise price $94.52, 271 shares of stock option with exercise price $84.61, 367 shares of stock option with exercise price $74.91, 119 restricted stock units, and 160 restricted stock units. |
| 02/03/2026 | Vesting date for 86 shares of stock option with exercise price $72.05, and 38 restricted stock units. |
| 08/07/2026 | Expiration date for a fully vested stock option with an exercise price of $47.60, held indirectly by significant other. |
| 08/15/2026 | Vesting date for 524 shares of stock option with exercise price $94.52, 271 shares of stock option with exercise price $84.61, 367 shares of stock option with exercise price $74.91, 118 restricted stock units, and 160 restricted stock units. |
| 02/03/2027 | Vesting date for 86 shares of stock option with exercise price $72.05, and 38 restricted stock units. |
| 08/05/2027 | Expiration date for a fully vested stock option with an exercise price of $66.97, held indirectly by significant other. |
| 08/15/2027 | Vesting date for 271 shares of stock option with exercise price $84.61, 367 shares of stock option with exercise price $74.91, and 160 restricted stock units. |
| 02/03/2028 | Vesting date for 86 shares of stock option with exercise price $72.05, and 39 restricted stock units. |
| 08/06/2028 | Expiration date for a stock option with an exercise price of $120.46, held indirectly by significant other. |
| 08/15/2028 | Vesting date for 367 shares of stock option with exercise price $74.91. |
| 02/03/2029 | Vesting date for 86 shares of stock option with exercise price $72.05. |
| 08/15/2029 | Expiration date for a stock option with an exercise price of $94.52, held indirectly by significant other. |
| 08/15/2030 | Expiration date for a stock option with an exercise price of $84.61, held indirectly by significant other. |
| 08/15/2034 | Expiration date for a stock option with an exercise price of $74.91, held indirectly by significant other. |
| 02/03/2035 | Expiration date for a stock option with an exercise price of $72.05, held directly. |
Keywords
BIO-TECHNE, TECH, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director Transactions, SEC Filing, Amy E. Herr, Share Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.